Fabio Sánchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fabio Sánchez has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Mona Ståhle
Dermatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Andor Pivarcsi
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
1 shared publication - Annelie Liljegren
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
1 shared publication - Bengt Sandstedt
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, 171 76, Sweden
1 shared publication - Clara Ibel Chamorro
Department of Women’s and Children’s Health, Karolinska Institutet, Biomedicum A4, Tomtebodavägen 16, Solna, 17165 Stockholm, Sweden
1 shared publication - Fredrik Granath
Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska University Hospital and Institute, T2, Stockholm, SE-171 76, Sweden
1 shared publication
Latest Publications
- Open Access
- 29 May 2009
- Published by Springer Nature in BMC Dermatology
- Vol. 9 (1) , 5
HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
The influence of streptococcal infections in the pathogenesis of psoriasis is not yet understood. In vitro data suggest that streptococcal factors influence T-cell function in psoriasis in a HLA-dependent manner, but studies designed to measure the HLA-C/Streptococci interaction are lacking. In the present study, we hypothesized that there is a statistical interaction between the result of streptococcal throat cultures and the presence of the HLA-Cw*0602 allele in psoriasis patients.
- 29 May 2009
- Published by Springer Nature in BMC Dermatology
- Vol. 9 (1) , 5
Open AccessHLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
The influence of streptococcal infections in the pathogenesis of psoriasis is not yet understood. In vitro data suggest that streptococcal factors influence T-cell function in psoriasis in a HLA-dependent manner, but studies designed to measure the HLA-C/Streptococci interaction are lacking. In the present study, we hypothesized that there is a statistical interaction between the result of streptococcal throat cultures and the presence of the HLA-Cw*0602 allele in psoriasis patients.
- Open Access
- 30 January 2009
- Published by Springer Nature in Breast Cancer Research
- Vol. 11 (1) , R6
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
Introduction: Human cathelicidin antimicrobial protein, hCAP18, and its C-terminal peptide LL-37 is a multifunctional protein. In addition to being important in antimicrobial defense, it induces chemotaxis, stimulates angiogenesis and promotes tissue repair. We previously showed that human breast cancer cells express high amounts of hCAP18, and hypothesised that hCAP18/LL-37 may be involved in tumour progression. Methods: hCAP18 mRNA was quantified in 109 primary breast cancers and compared with clinical findings and ERBB2 mRNA expression. Effects of exogenous LL-37 and transgenic overexpression of hCAP18 on ErbB2 signalling were investigated by immunoblotting using extracts from breast cancer cell lines ZR75-1 and derivatives of MCF7. We further analysed the impact of hCAP18/LL-37 on the morphology of breast cancer cells grown in soft agar, on cell migration and on tumour development in severe combined immunodeficiency (SCID) mice. Results: The expression of hCAP18 correlated closely with that of ERBB2 and with the presence of lymph node metastases in oestrogen receptor-positive tumours. hCAP18/LL-37 amplified Heregulin-induced mitogen-activated protein kinase (MAPK) signalling through ErbB2, identifying a functional association between hCAP18/LL-37 and ErbB2 in breast cancer. Treatment with LL-37 peptide significantly stimulated the migration of breast cancer cells and their colonies acquired a dispersed morphology indicative of increased metastatic potential. A truncated version of LL-37 competitively inhibited LL-37 induced MAPK phosphorylation and significantly reduced the number of altered cancer cell colonies induced by LL-37 as well as suppressed their migration. Transgenic overexpression of hCAP18 in a low malignant breast cancer cell line promoted the development of metastases in SCID mice, and analysis of hCAP18 transgenic tumours showed enhanced activation of MAPK signalling. Conclusions: Our results provide evidence that hCAP18/LL-37 contributes to breast cancer metastasis.
- 30 January 2009
- Published by Springer Nature in Breast Cancer Research
- Vol. 11 (1) , R6
Open AccessHuman antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
Introduction: Human cathelicidin antimicrobial protein, hCAP18, and its C-terminal peptide LL-37 is a multifunctional protein. In addition to being important in antimicrobial defense, it induces chemotaxis, stimulates angiogenesis and promotes tissue repair. We previously showed that human breast cancer cells express high amounts of hCAP18, and hypothesised that hCAP18/LL-37 may be involved in tumour progression. Methods: hCAP18 mRNA was quantified in 109 primary breast cancers and compared with clinical findings and ERBB2 mRNA expression. Effects of exogenous LL-37 and transgenic overexpression of hCAP18 on ErbB2 signalling were investigated by immunoblotting using extracts from breast cancer cell lines ZR75-1 and derivatives of MCF7. We further analysed the impact of hCAP18/LL-37 on the morphology of breast cancer cells grown in soft agar, on cell migration and on tumour development in severe combined immunodeficiency (SCID) mice. Results: The expression of hCAP18 correlated closely with that of ERBB2 and with the presence of lymph node metastases in oestrogen receptor-positive tumours. hCAP18/LL-37 amplified Heregulin-induced mitogen-activated protein kinase (MAPK) signalling through ErbB2, identifying a functional association between hCAP18/LL-37 and ErbB2 in breast cancer. Treatment with LL-37 peptide significantly stimulated the migration of breast cancer cells and their colonies acquired a dispersed morphology indicative of increased metastatic potential. A truncated version of LL-37 competitively inhibited LL-37 induced MAPK phosphorylation and significantly reduced the number of altered cancer cell colonies induced by LL-37 as well as suppressed their migration. Transgenic overexpression of hCAP18 in a low malignant breast cancer cell line promoted the development of metastases in SCID mice, and analysis of hCAP18 transgenic tumours showed enhanced activation of MAPK signalling. Conclusions: Our results provide evidence that hCAP18/LL-37 contributes to breast cancer metastasis.
- 1 July 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (7) , 1704-1709
IFN-Regulatory Factor 5 Gene Variants Interact with the Class I MHC Locus in the Swedish Psoriasis Population
- 1 July 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (7) , 1704-1709
IFN-Regulatory Factor 5 Gene Variants Interact with the Class I MHC Locus in the Swedish Psoriasis Population